DeveloGen AG

DeveloGen is a leading biotechnology company developing innovative gene-based medicines. By applying novel functional genomic and gene discovery techniques to developmental biology, DeveloGen has pioneered programs in diabetes, obesity and liver regeneration. In 1999, DeveloGen and its founders were awarded the German President's prize for innovation. In May 2000, DeveloGen merged with HepaVec AG - Germany's leading gene delivery and liver disease biotechnology company. To date the company has 70 employees in its research laboratories in Göttingen and Berlin. Corporate headquarters are located in Göttingen. The merged company, which will keep the DeveloGen name, combines the rapid gene discovery and functional genomics strengths of DeveloGen, with the innovative gene delivery technology pioneered by HepaVec.

Contact Details: Rudolf-Wissell-Str. 28 Göttingen D-37079 Germany Tel: +49 (0) 551 5055861 Fax: +49 (0) 551 5055886 Email: WWW: www.develogen.com/

Recent Publications by DeveloGen AG:
Inhibition of GSK3 promotes replication and survival of pancreatic beta cells. Recent developments indicate that the regeneration of beta cell function...	1st June, 2007	DeveloGen AG, Marie-Curie-Strasse 7, Gottingen 37079, Germany.	J Biol Chem. 2007 Apr 20;282(16):12030-7. Epub 2007 Jan 22. DOI Direct Link
Obesity and related disorders--SMi's Second Annual Conference. Recent developments indicate that the regeneration of beta cell function...	29th July, 2005	DeveloGen AG, Rudolf-Wissell Strasse 28, D-37079 Gottingen, Germany.	IDrugs. 2005 Apr;8(4):297-8.
Phenotype-first screening for the identification of novel drug targets. Modern drug discovery is predominantly a target-driven process, where...	13th July, 2005	DeveloGen AG, Rudolf-Wissell-Strasse 28, 37079 Gottingen, Germany.	Drug Discov Today. 2005 Feb 15;10(4):275-82. DOI Direct Link
Target discovery in metabolic disease. The prevalence of metabolic diseases is taking on epidemic proportions and...	24th December, 2004	DeveloGen AG, Rudolf-Wissell Strasse 28, 37079 Goettingen, Germany.	Drug Discov Today. 2004 Sep 15;9(18):785-94. DOI Direct Link
Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice. Ovine atadenovirus (OAdV) is a novel gene transfer vector with excellent...	19th October, 2004	DeveloGen AG, Rudolf-Wissell-Str. 28, 37092 Gottingen, Germany.	Vaccine. 2004 Jul 29;22(21-22):2717-21. DOI Direct Link
→View more DeveloGen AG research publications.

BioNews Results for DeveloGen AG:
BIOTECHNICA Promotes Dialogue on European Biotech Goals	Pharma Live:  Oct 5 2008 7:50AM Matching: ag
New Study Finds Type of HRT Is Key With Regard to MI Risk	Medscape:  Oct 3 2008 10:46PM Matching: ag
MediGene Spins Out mTCR Programme - Independent Company Immunocore Limited Founded	Pharma Live:  Oct 4 2008 9:44PM Matching: ag
Exit Strategies: Creating the Rest of Your Life	Review of Ophthalmology:  Oct 4 2008 6:47AM Matching: ag
AntiAging Congress Alert: Hormone Myths vs. Medical Literature and How to Grow Your Own Stem Cells	24-7PressRelease.com:  Oct 4 2008 3:57PM Matching: ag
Promote your company here: BioNewsCast - Press Release Distribution	→View more DeveloGen AG news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 219 times since April 2007, the link to the organisation's website has been followed 33 times

Recent Search Terms used to find this page: develogen.com -info | develogen | DeveloGen Vaccine | develogen | develogen | employees in DeveloGen | .

Search for more companies in Göttingen

Search for more companies in

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for DeveloGen AG